118 related articles for article (PubMed ID: 32299611)
1. PFKFB4 is critical for the survival of acute monocytic leukemia cells.
Wang G; Li S; Xue K; Dong S
Biochem Biophys Res Commun; 2020 Jun; 526(4):978-985. PubMed ID: 32299611
[TBL] [Abstract][Full Text] [Related]
2. Ets1 Plays a Critical Role in MLL/EB1-Mediated Leukemic Transformation in a Mouse Bone Marrow Transplantation Model.
Fu JF; Yen TH; Huang YJ; Shih LY
Neoplasia; 2019 May; 21(5):469-481. PubMed ID: 30974389
[TBL] [Abstract][Full Text] [Related]
3. [Effect of down-regulating mll-af9 gene expression on proliferation of acute monocytic leukemia cell line THP-1].
Li L; Zhang AH; Liu LB; Bi L; Wang L; Zhao YJ; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):254-7. PubMed ID: 18426643
[TBL] [Abstract][Full Text] [Related]
4. Generation of a MLL-AF9-specific stem cell model of acute monocytic leukemia.
Chiew MY; Boo NY; Voon K; Cheong SK; Leong PP
Leuk Lymphoma; 2017 Jan; 58(1):162-170. PubMed ID: 27185517
[TBL] [Abstract][Full Text] [Related]
5. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
[TBL] [Abstract][Full Text] [Related]
6. [Mutational detection of full-length mixed lineage leukemia gene in patients with de novo AML-M4 and M5].
Wang QR; Shi JY; Shi L; Chen SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):12-7. PubMed ID: 22391156
[TBL] [Abstract][Full Text] [Related]
7. Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia.
Brzezinka K; Nevedomskaya E; Lesche R; Steckel M; Eheim AL; Haegebarth A; Stresemann C
J Hematol Oncol; 2019 Jun; 12(1):66. PubMed ID: 31253180
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of MLL-AF9, MLL and MYC expression is not obligatory for monocyte-macrophage maturation in AML-M5 cell lines carrying t(9;11)(p22;q23).
Martino V; Tonelli R; Montemurro L; Franzoni M; Marino F; Fazzina R; Pession A
Oncol Rep; 2006 Jan; 15(1):207-11. PubMed ID: 16328057
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic and molecular analysis of the acute monocytic leukemia cell line THP-1 with an MLL-AF9 translocation.
Odero MD; Zeleznik-Le NJ; Chinwalla V; Rowley JD
Genes Chromosomes Cancer; 2000 Dec; 29(4):333-8. PubMed ID: 11066077
[TBL] [Abstract][Full Text] [Related]
10. Piribedil disrupts the MLL1-WDR5 interaction and sensitizes MLL-rearranged acute myeloid leukemia (AML) to doxorubicin-induced apoptosis.
Zhang X; Zheng X; Yang H; Yan J; Fu X; Wei R; Xu X; Zhang Z; Yu A; Zhou K; Ding J; Geng M; Huang X
Cancer Lett; 2018 Sep; 431():150-160. PubMed ID: 29857126
[TBL] [Abstract][Full Text] [Related]
11. The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia.
Baker A; Gregory GP; Verbrugge I; Kats L; Hilton JJ; Vidacs E; Lee EM; Lock RB; Zuber J; Shortt J; Johnstone RW
Cancer Res; 2016 Mar; 76(5):1158-69. PubMed ID: 26627013
[TBL] [Abstract][Full Text] [Related]
12. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
[TBL] [Abstract][Full Text] [Related]
13. AURKA Suppresses Leukemic THP-1 Cell Differentiation through Inhibition of the KDM6B Pathway.
Park JW; Cho H; Oh H; Kim JY; Seo SB
Mol Cells; 2018 May; 41(5):444-453. PubMed ID: 29477140
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel RAS GTPase-activating protein (RASGAP) gene at 9q34 as an MLL fusion partner in a patient with de novo acute myeloid leukemia.
von Bergh AR; Wijers PM; Groot AJ; van Zelderen-Bhola S; Falkenburg JH; Kluin PM; Schuuring E
Genes Chromosomes Cancer; 2004 Apr; 39(4):324-34. PubMed ID: 14978793
[TBL] [Abstract][Full Text] [Related]
16. ALL-1 gene rearrangements in acute myeloid leukemia: association with M4-M5 French-American-British classification subtypes and young age.
Cimino G; Rapanotti MC; Elia L; Biondi A; Fizzotti M; Testi AM; Tosti S; Croce CM; Canaani E; Mandelli F
Cancer Res; 1995 Apr; 55(8):1625-8. PubMed ID: 7712464
[TBL] [Abstract][Full Text] [Related]
17. mTOR up-regulation of PFKFB3 is essential for acute myeloid leukemia cell survival.
Feng Y; Wu L
Biochem Biophys Res Commun; 2017 Feb; 483(2):897-903. PubMed ID: 28082200
[TBL] [Abstract][Full Text] [Related]
18. An Infant With Congenital Leukemia Cutis and AML-M5 With MLL Gene Rearrangement.
Bayhan T; Çiki K; Tavil B; Gümrük F; Çetin M; Ünal Ş
J Pediatr Hematol Oncol; 2015 Oct; 37(7):566-7. PubMed ID: 26207776
[No Abstract] [Full Text] [Related]
19. Rac1 signaling protects monocytic AML cells expressing the MLL-AF9 oncogene from caspase-mediated apoptotic death.
Hinterleitner C; Huelsenbeck J; Henninger C; Wartlick F; Schorr A; Kaina B; Fritz G
Apoptosis; 2013 Aug; 18(8):963-79. PubMed ID: 23624644
[TBL] [Abstract][Full Text] [Related]
20. Hsp27: a novel therapeutic target for pediatric M4/M5 acute myeloid leukemia.
Yang L; Cao L; Yang M; Tang D; Kang R; Min X; Zhu S; Yu Y
Oncol Rep; 2013 Apr; 29(4):1459-66. PubMed ID: 23404246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
